New Proinsulin Study Findings Have Been Reported from T. Logan et al (Evaluating the Managed Care Implications of Longer-Acting Basal Insulin Analog…

Insurance Weekly News

New Proinsulin Study Findings Have Been Reported from T. Logan et al (Evaluating the Managed Care Implications of Longer-Acting Basal Insulin Analog Therapies)

By a News Reporter-Staff News Editor at Insurance Weekly News -- Data detailed on Peptide Proteins - Proinsulin have been presented. According to news reporting from Nashville, Tennessee, by VerticalNews journalists, research stated, "Diabetes, particularly type 2 diabetes (T2D), has become an epidemic in the United States, with a significant portion of patients unable to meet recommended glycemic targets. All individuals with type 1 diabetes (T1D) and a significant majority of those with T2D will ultimately require insulin therapy."

The news correspondents obtained a quote from the research, "However, there are several barriers to its use. The introduction of the new, ultra-long-acting basal insulins degludec and glargine U-300, and the single-injection combinations of insulin degludec/liraglutide and insulin glargine U-100/lixisenatide, offer options that may overcome several of those barriers, including the high risk of hypoglycemia, glycemic variability, and relatively short duration of action. This article spotlights the outcomes of the phase 3 clinical trials for these newer formulations, as well as more recent meta-analyses and real-world studies."

According to the news reporters, the research concluded: "It also highlights the implications for managed care plans as they move to add these insulins to their formularies."

For more information on this research see: Evaluating the Managed Care Implications of Longer-Acting Basal Insulin Analog Therapies. American Journal of Managed Care, 2018;24(6):S93-S101. American Journal of Managed Care can be contacted at: Managed Care & Healthcare Communications Llc, 666 Plainsboro Rd, Ste 300, Plainsboro, NJ 08536, USA.

Our news journalists report that additional information may be obtained by contacting T. Logan, MedHere Today Consulting, Nashville, TN 37214, United States.

Keywords for this news article include: Nashville, Tennessee, United States, North and Central America, Health and Medicine, Peptide Proteins, Peptide Hormones, Epidemiology, Managed Care, Proinsulin.